View this post on the web at [link removed]

The latest data from the Vaccine Adverse Event Reporting System (VAERS) released today reinforces the continuous climb of adverse events and deaths attributed to COVID-19 vaccines.
Between Dec. 14, 2020, and Jan. 6, 2023, 1,499,447 [ [link removed] ]adverse events were reported to VAERS attributed to COVID-19 vaccines. This includes 33,591 reports [ [link removed] ] of deaths and 274,823 serious injuries [ [link removed] ]. Of the 33,591 reported deaths, 21,147 cases [ [link removed] ] are attributed to Pfizer, 9,359 [ [link removed] ]to Moderna, 2,904 [ [link removed] ]to Johnson & Johnson, and 0 [ [link removed] ]to Novavax. Of the reported deaths [ [link removed] ], 9% occurred within 24 hours of vaccination, and 13% occurred within 48 hours of vaccination.
VAERS is a voluntary reporting system co-managed by the U.S. Food and Drug Administration and Centers for Disease Control and Prevention (CDC) designed to detect vaccine safety signals. The data released is usually one week behind, so data released today, on Jan. 13, reflects reports up to Jan. 6, 2023.
Excluding “foreign reports [ [link removed] ]” to VAERS, 922,020 adverse events [ [link removed] ], including 16,315 deaths [ [link removed] ] and 97,533 serious injuries [ [link removed] ], were reported in the U.S. between Dec. 14, 2020, and Jan. 6, 2023.
Foreign reports [ [link removed] ] are reports from foreign subsidiaries sent to U.S. vaccine manufacturers. Under FDA regulations, if a manufacturer is notified of a foreign case report describing an event that is both serious and does not appear on the product’s labeling, the manufacturer must submit the report to VAERS.
In the U.S., 664 million COVID-19 vaccine doses [ [link removed] ] had been given as of Jan. 4, including 396 million doses of Pfizer, 249 million doses of Moderna, 19 million doses of Johnson & Johnson, and 70,000 doses of Novavax.
Megan Redshaw is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.
Bivalent Booster Data
As of Jan. 4, 48 million people [ [link removed] ] received an untested, updated bivalent booster dose targeting the no-longer-existing Wuhan strain and obsolete BA.4/BA.5 omicron subvariants.
Between the rollout of bivalent boosters in September 2022 and Jan. 6, there were 16,525 adverse events [ [link removed] ] reported to VAERS, with 43% attributed to Moderna’s booster [ [link removed] ] and 57% attributed to Pfizer/BioNTech [ [link removed] ]. The data included 133 deaths [ [link removed] ], 1,060 serious injuries [ [link removed] ], and 51 reports [ [link removed] ] of myocarditis and pericarditis (heart inflammation).
Note the CDC uses a narrowed case definition [ [link removed] ] of “myocarditis,” which allows them to exclude cases of cardiac arrest, ischemic strokes, and deaths due to heart problems that occur before one has the chance to go to the hospital, obtain a diagnosis, or “dies suddenly.”
To meet the case definition of myocarditis, people must have had “symptoms such as chest pain, shortness of breath and feelings of having a fast-beating, fluttering or pounding heart, and medical tests to support the diagnosis of myocarditis and rule out other causes.”
The CDC website does not state what happens to these cases, but there is no indication they are tracked or included in the CDC’s myocarditis numbers.
According to the CDC, VAERS data available to the public [ [link removed] ] include the initial reports to VAERS. Any updates or corrections to reports during follow-up are used by the government for analysis but are not made available to the public. In other words, we may see an initial report for a heart problem that later leads to death, but we will not see an updated report if a person dies, nor will that death be included in the statistics. It’s all very “transparent.”
Data for 6-month-olds to 5-year-olds
5,482 adverse events [ [link removed] ], including 223 cases rated as serious [ [link removed] ] and 13 reported deaths [ [link removed] ].
5 reports [ [link removed] ] of myocarditis and pericarditis.
33 reports [ [link removed] ] of blood clotting disorders.
56 reports [ [link removed] ] of seizures.
Data for 5- to 11-year-olds
16,567 adverse events [ [link removed] ], including 747 rated as serious [ [link removed] ] and 33 reported deaths [ [link removed] ].
48 reports [ [link removed] ] of myocarditis and pericarditis.
74 reports [ [link removed] ] of blood clotting disorders.
192 reports [ [link removed] ] of seizures.
Data for 12- to 17-year-olds
40,982 adverse events [ [link removed] ], including 4,481 rated as serious [ [link removed] ] and 135 reported deaths [ [link removed] ].
273 reports [ [link removed] ] of anaphylaxis among 12- to 17-year-olds where the reaction was life-threatening, required treatment, or resulted in death.
1,341 reports [ [link removed] ] of myocarditis and pericarditis, with 1,174 cases [ [link removed] ] attributed to Pfizer’s vaccine.
306 reports [ [link removed] ] of blood clotting disorders, with 280 cases [ [link removed] ] attributed to Pfizer.
29 cases [ [link removed] ] of postural orthostatic tachycardia syndrome (POTS), with all cases attributed to Pfizer’s vaccine.
Data for all age groups to VAERS
16% of deaths were related to cardiac disorders.
53% of those who died were male [ [link removed] ], and 41% were female [ [link removed] ]. The remaining death reports do not list the gender of the deceased.
The average age [ [link removed] ] of death was 72.
As of Jan. 6, 8,886 pregnant women [ [link removed] ] reported adverse events related to COVID-19 vaccines, including 5,148 reports [ [link removed] ] of miscarriage or premature birth.
Of the 16,922 cases of Bell’s palsy [ [link removed] ] reported, 73% were attributed to Pfizer vaccinations, 22% to Moderna [ [link removed] ], and 5% to J&J [ [link removed] ].
3,168 reports [ [link removed] ] of Guillain-Barré syndrome.
10,297 reports [ [link removed] ] of anaphylaxis where the reaction was life-threatening, required treatment, or resulted in death.
8,248 reports [ [link removed] ] of myocardial infarction and cardiac arrest.
45,093 reports [ [link removed] ] of blood-clotting disorders. Of those, 30,916 reports [ [link removed] ] were attributed to Pfizer, 10,200 reports [ [link removed] ] to Moderna, and 3,901 reports [ [link removed] ] to Johnson & Johnson.
25,056 cases [ [link removed] ] of myocarditis and pericarditis, with 18,988 cases [ [link removed] ] attributed to Pfizer, 5,575 cases [ [link removed] ] to Moderna, and 435 [ [link removed] ]to Johnson & Johnson.
78 cases [ [link removed] ] of Creutzfeldt-Jakob disease, with 64 cases [ [link removed] ] attributed to Pfizer, 12 [ [link removed] ]to Moderna, and 2 [ [link removed] ]to J&J.
635 cases [ [link removed] ] of POTS, with 462 cases [ [link removed] ] attributed to Pfizer, 147 cases [ [link removed] ] to Moderna, and 25 cases [ [link removed] ] to Johnson & Johnson.
VAERS is estimated [ [link removed] ] to represent only 1% of actual adverse events. Reports submitted require further investigation before a causal relationship can be confirmed; however, U.S. regulatory agencies neither properly investigate nor acknowledge causal relationships between adverse events and COVID-19 vaccines.
Although healthcare providers are required by law to report vaccine adverse events to VAERS, research shows very few do. It is essential that anyone who experiences an adverse event report their own injury [ [link removed] ].
Megan Redshaw is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

Unsubscribe [link removed]?